Olli Jaaskelainen

Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

Journal: BMJ neurology open

Published: July 30, 2025

The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis.

The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: October 27, 2023

Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI.

Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI.

Journal: International journal of molecular sciences

Published: October 05, 2022

Circulating neurofilament is linked with morbid obesity, renal function, and brain density.

Circulating neurofilament is linked with morbid obesity, renal function, and brain density.

Journal: Scientific reports

Published: January 04, 2022

Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.

Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: September 04, 2021

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions.

Journal: Neuroradiology

Published: April 27, 2021

GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.

GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 25, 2021

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.

Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.

Journal: Dementia and geriatric cognitive disorders

Published: November 09, 2020

Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.

Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.

Journal: Journal of Alzheimer's disease : JAD

Published: April 21, 2020

Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.

Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.

Journal: Brain and behavior

Published: April 19, 2020

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.

Journal: Annals of clinical and translational neurology

Published: February 12, 2020

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: February 03, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026